Monsanto: Q2 below estimates

(CercleFinance.com) - Monsanto unveiled Q2 EPS on a continuing basis of 3.
22 dollars, up 1% y-o-y, albeit nine cents short of the consensus.

The agro-chemist Saint Louis saw its sales stagnate at around 5 billion dollars, despite a rise in glyphosate prices, which supported revenues of its agricultural productivity division.

In addition, Monsanto is optimistic about the proposed merger with the German group Bayer, with the deal having already obtained the go-ahead from the European Commission, the Chinese and Brazilian competition authorities.


Copyright (c) 2018 CercleFinance.com. All rights reserved.